Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Product Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 360.5M | 185.34M | +105.81% |
| Sep 30, 2024 | 175.16M | 13.88M | +8.61% |
| Jun 30, 2024 | 161.28M | 16.43M | +11.35% |
| Mar 31, 2024 | 144.84M | 13.34M | +10.14% |
| Dec 31, 2023 | 131.51M | 5.7M | +4.53% |
| Sep 30, 2023 | 125.81M | 15.68M | +14.24% |
| Jun 30, 2023 | 110.13M | 109.55M | +19052.70% |
| Mar 31, 2023 | 575K | 139K | +31.88% |
| Dec 31, 2022 | 436K | 436K | n/a |
| Sep 30, 2022 | 0 | -505K | -100.00% |
| Jun 30, 2022 | 505K | 264K | +109.54% |
| Mar 31, 2022 | 241K | 86.1K | +55.58% |
| Dec 31, 2021 | 154.9K | -446.14K | -74.23% |
| Sep 30, 2021 | 601.04K | -438.74K | -42.20% |
| Jun 30, 2021 | 1.04M | 740.36K | +247.26% |
| Mar 31, 2021 | 299.42K | -12.1M | -97.59% |
| Dec 31, 2020 | 12.4M | 5.04M | +68.33% |
| Sep 30, 2020 | 7.37M | 5.49M | +292.81% |
| Jun 30, 2020 | 1.88M | 993.37K | +112.56% |
| Mar 31, 2020 | 882.52K | n/a | n/a |